Patent Yard Sign in
Canadian application, no grantCanada

Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer

CA 2440703 A1 · Owner: Gish, Kurt C. · Inventors: Gish, Kurt C.; Mack, David H.; Afar, Daniel

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Described herein are genes whose expression are up-regulated or down-regulated in breast cancer. Related methods, and compositions that can be used for diagnosis and treatment of breast cancer are disclosed. Also described herein are methods that can be used to identify modulators of breast cancer.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed January 24, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 24, 2022.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 24, 2024.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJanuary 24, 2002
GrantedNo grant recorded
Term endedJanuary 24, 2022
Patent numberCA 2440703 A1
Classification (IPC)C07K14/47

Timeline

Timeline From CIPO dates

2003200520072009201120132015201720192021Application filedJan 24, 2002Term endedJan 24, 2022

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.